The present invention relates to a dengue hemorrhagic fever virus vaccine containing a common 30 nucleotide deletion (D32) in the 3'-alpha_region. Dengue hemorrhagic fever virus antigens of serotypes 1, 2, 3 and 4 on chromosome Y are chimeric, or dengue hemorrhagic fever virus of serotypes 1, 2, 3 and 4.
展开▼